Transdel Pharmaceuticals, Inc.
OTCBB:TDLP,OB
Transdel Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs. The Company's lead topical drug, Ketotransdel(TM), utilizes the Company's proprietary Transdel(TM) cream formulation to facilitate the passage of ketoprofen, an NSAID, through the epidermis and into underlying tissues where the drug exerts its prolonged localized anti-inflammatory effect. The Company is also investigating other drug candidates and treatments for transdermal delivery using the Transdel(TM) platform technology for products in pain management and human hormone replacement, amongst others.